Empyrean Technology (301269) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
6 Jun, 2025Executive summary
Q1 2025 revenue reached RMB 234.32 million, up 9.77% year-over-year; net profit attributable to shareholders was RMB 9.71 million, a 26.72% increase year-over-year.
Operating cash flow surged 281.38% to RMB 240.26 million compared to the same quarter last year.
Basic and diluted EPS both rose to RMB 0.02, doubling from RMB 0.01 in Q1 2024.
Financial highlights
Gross margin improved as operating costs increased at a slower rate than revenue; operating costs were RMB 20.11 million, up 175.77% year-over-year.
Net assets attributable to shareholders increased 1.26% from year-end 2024 to RMB 5.07 billion.
Total assets decreased 2.45% to RMB 5.49 billion compared to year-end 2024.
Non-recurring gains (mainly government subsidies and VAT rebates) contributed RMB 10.10 million to profit.
Key financial ratios and metrics
Weighted average ROE was 0.19%, up from 0.16% in Q1 2024.
Basic and diluted EPS both at RMB 0.02, up 100% year-over-year.
Operating cash flow margin improved significantly due to higher collections and lower outflows.
Latest events from Empyrean Technology
- Revenue up 20.98%, net profit down 45.46%, R&D at 71% of sales, new actual controller.301269
H2 202418 Dec 2025 - Revenue up, profit down sharply as costs rise; cash flow strong, subsidies key.301269
Q3 202530 Oct 2025 - Revenue up 13%, net profit down 91.9% on high R&D; new EDA tools and strong overseas growth.301269
H1 202520 Aug 2025 - Revenue up, profit down sharply as costs rise and new EDA products launch.301269
Q3 202413 Jun 2025 - Revenue up 9.6% but net profit down 54.8% as R&D investment hits 78.7% of sales.301269
H1 202413 Jun 2025